Lynchburg Journal of Medical Science
A review of the recent literature found that compared to placebo or other pain medications, Gabapentin did not significantly reduce non-neuropathic pain. Further, Gabapentin is associated with an increased risk of adverse events compared with placebo, including somnolence, dizziness, and nausea. Given the lack of efficacy and risk of adverse events, Gabapentin should not be used for non-neuropathic pain.
Migeon M. Is Gabapentin a Safe and Effective Treatment for Non-Neuropathic Pain?. Lynchburg Journal of Medical Science. 2020; 2(3).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.